Publication | Closed Access

The GC–MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology

MedicineMetabolomic ProfilingPathologyBiomarkersFibromyalgia Syndrome DirectsFms PathophysiologyMetabolomicsMicrobiomeGc–ms Metabolomics SignatureFibromyalgiaPathophysiologyMetabolic Profiling